Moleculin Biotech amends bylaws; reduces stockholder quorum from majority to one-third

Moleculin Biotech, Inc.

Board adopted Third Amended and Restated Bylaws effective August 18, 2023.
Quorum for stockholder meetings reduced from majority to one-third of voting power.
Directors may be removed with or without cause by majority vote.
Updated procedures for stockholder proposals and remote meeting capability.
Conforming changes and updates consistent with Delaware law.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Moleculin Biotech, Inc.: Board adopted Third Amended and Restated Bylaws effective August 18, 2023, with multiple changes including reduced stockholder meeting quorum from majority to one-third of voting power (effective 2023-08-18).

Change: bylaw amendment
Effective: 2023-08-18

Exact text from the filing

On August 18, 2023, the Board of Directors of Moleculin Biotech, Inc. (the “Company”) adopted the Third Amended and Restated Bylaws of Moleculin Biotech, Inc. (as amended and restated, the “Bylaws”), effective on such date.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Moleculin Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-024329

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.